Analysts Set Revolution Medicines, Inc. (NASDAQ:RVMD) Target Price at $66.67
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has received an average rating of “Buy” from the twelve research firms that are covering the company, Marketbeat reports. Twelve analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have issued a report on the stock in the […]
